Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

• Last SEC data release: 2025-03-14
• Last 15 days FTD volume: A$0 M
• Last 3 months FTD volume: A$1.45 M
• Last year FTD volume: A$1.45 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2022

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Baxter BAX	A$22.31 M	A$52.9 M	🇺🇸 USA
Geron GERN	A$5.14 M	A$26.95 M	🇺🇸 USA
Omeros Corporation OMER	A$1.78 M	A$6.33 M	🇺🇸 USA
Sanofi SNY	A$6.86 M	A$53.59 M	🇫🇷 France
Bio-Techne TECH	A$0.56 M	A$17.99 M	🇺🇸 USA
Genetic Technologies GENE	N/A	A$1.12 M	🇦🇺 Australia
Teva Pharmaceutical Industries TEVA	A$13.08 M	A$42.43 M	🇮🇱 Israel